Page 883 - Read Online

Ghuman et al. Mini-invasive Surg 2020;4:84 I http://dx.doi.org/10.20517/2574-1225.2020.88 Page 5 of 6

the care model to continue improving patient care. Regardless of what surgical technique is chosen by the
surgeon, a multidisciplinary team approach must be applied to optimize oncologic outcomes [31,32] .

DECLARATIONS
Authors’ contributions
Manuscript preparation: Ghuman A, Kavalukas S
Manuscript review and editing: Wexner SD

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Dr. Wexner is a paid consultant and receives royalties for intellectual property license from Intuitive
Surgical, Medtronic, and Karl Storz and is a paid consultant for Stryker, Takeda, and Baxter. All other
authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 1982;69:613-6.
2. Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on
pathologic outcomes. JAMA 2015;314:1346-55.
3. Fleshman J, Branda ME, Sargent DJ, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open
resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 2019;269:589-95.
4. Bonjer HJ, Deijen CL, Abis GA, et al. COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer.
N Engl J Med 2015;372:1324-32.
5. van der Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a
randomised, phase 3 trial. Lancet Oncol 2013;14:210-8.
6. Stevenson AR, Solomon MJ, Lumley JW, et al. ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on
pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314:1356-63.
7. Kang S, Park JW, Jeong S, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy
(COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010;11:637-45.
8. Jeong S, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant
chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol
2014;15:767-74.
9. Holder-Murray J, Dozois EJ. Minimally invasive surgery for colorectal cancer: past, present, and future. Int J Surg Oncol
2011;2011:490917.
10. Jayne D, Pigazzi A, Marshall H, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open
laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 2017;318:1569-80.
11. Kim MJ, Park SC, Park JW, et al. Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective
randomized controlled trial. Ann Surg 2018;267:243-51.
12. Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized
trial. Surg Endosc 2008;22:1601-8.